These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
398 related articles for article (PubMed ID: 19875950)
1. Fractionated stereotactic body radiation therapy in the treatment of previously-irradiated recurrent head and neck carcinoma: updated report of the University of Pittsburgh experience. Rwigema JC; Heron DE; Ferris RL; Gibson M; Quinn A; Yang Y; Ozhasoglu C; Burton S Am J Clin Oncol; 2010 Jun; 33(3):286-93. PubMed ID: 19875950 [TBL] [Abstract][Full Text] [Related]
2. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study. Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M; Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206 [TBL] [Abstract][Full Text] [Related]
3. Stereotactic body radiation therapy for primary, recurrent, and metastatic tumors in the head-and-neck region. Siddiqui F; Patel M; Khan M; McLean S; Dragovic J; Jin JY; Movsas B; Ryu S Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1047-53. PubMed ID: 19327895 [TBL] [Abstract][Full Text] [Related]
4. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience. Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834 [TBL] [Abstract][Full Text] [Related]
5. Fractionated stereotactic radiotherapy as reirradiation for locally recurrent head and neck cancer. Roh KW; Jang JS; Kim MS; Sun DI; Kim BS; Jung SL; Kang JH; Yoo EJ; Yoon SC; Jang HS; Chung SM; Kim YS Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1348-55. PubMed ID: 19117695 [TBL] [Abstract][Full Text] [Related]
6. Salvage stereotactic reirradiation with or without cetuximab for locally recurrent head-and-neck cancer: a feasibility study. Comet B; Kramar A; Faivre-Pierret M; Dewas S; Coche-Dequeant B; Degardin M; Lefebvre JL; Lacornerie T; Lartigau EF Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):203-9. PubMed ID: 22331006 [TBL] [Abstract][Full Text] [Related]
7. Intensity-modulated radiotherapy with concurrent chemotherapy for previously irradiated, recurrent head and neck cancer. Biagioli MC; Harvey M; Roman E; Raez LE; Wolfson AH; Mutyala S; Han HS; Markoe A Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1067-73. PubMed ID: 17967302 [TBL] [Abstract][Full Text] [Related]
8. The role of pulsed-dose-rate brachytherapy in previously irradiated head-and-neck cancer. Strnad V; Geiger M; Lotter M; Sauer R Brachytherapy; 2003; 2(3):158-63. PubMed ID: 15062138 [TBL] [Abstract][Full Text] [Related]
9. Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases. Rusthoven KE; Kavanagh BD; Cardenes H; Stieber VW; Burri SH; Feigenberg SJ; Chidel MA; Pugh TJ; Franklin W; Kane M; Gaspar LE; Schefter TE J Clin Oncol; 2009 Apr; 27(10):1572-8. PubMed ID: 19255321 [TBL] [Abstract][Full Text] [Related]
10. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma. Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654 [TBL] [Abstract][Full Text] [Related]
12. High-dose-rate interstitial brachytherapy in recurrent and previously irradiated head and neck cancers--preliminary results. Narayana A; Cohen GN; Zaider M; Chan K; Lee N; Wong RJ; Boyle J; Shaha A; Kraus D; Shah J; Zelefsky MJ Brachytherapy; 2007; 6(2):157-63. PubMed ID: 17434110 [TBL] [Abstract][Full Text] [Related]
13. IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes. Sulman EP; Schwartz DL; Le TT; Ang KK; Morrison WH; Rosenthal DI; Ahamad A; Kies M; Glisson B; Weber R; Garden AS Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):399-409. PubMed ID: 18556144 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of concomitant chemoradiation and surgical salvage for N3 nodal disease associated with upper aerodigestive tract carcinoma. Ahmed KA; Robbins KT; Wong F; Salazar JE Laryngoscope; 2000 Nov; 110(11):1789-93. PubMed ID: 11081585 [TBL] [Abstract][Full Text] [Related]
15. Induction chemotherapy followed by concomitant TFHX chemoradiotherapy with reduced dose radiation in advanced head and neck cancer. Haraf DJ; Rosen FR; Stenson K; Argiris A; Mittal BB; Witt ME; Brockstein BE; List MA; Portugal L; Pelzer H; Weichselbaum RR; Vokes EE Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5936-43. PubMed ID: 14676118 [TBL] [Abstract][Full Text] [Related]
16. Intensity-modulated radiotherapy for head and neck cancer of unknown primary: toxicity and preliminary efficacy. Klem ML; Mechalakos JG; Wolden SL; Zelefsky MJ; Singh B; Kraus D; Shaha A; Shah J; Pfister DG; Lee NY Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1100-7. PubMed ID: 17980501 [TBL] [Abstract][Full Text] [Related]
17. [Cytoprotection with amifostine in the framework of radiochemotherapy in previously irradiated head and neck carcinoma]. Büntzel J; Glatzel M; Schuth J; Weinaug R; Küttner K; Fröhlich D Strahlenther Onkol; 1999 Nov; 175 Suppl 4():37-40. PubMed ID: 10584140 [TBL] [Abstract][Full Text] [Related]
18. Image-guided radiosurgery of head and neck cancers. Ryu S; Khan M; Yin FF; Concus A; Ajlouni M; Benninger MS; Kim JH Otolaryngol Head Neck Surg; 2004 Jun; 130(6):690-7. PubMed ID: 15195054 [TBL] [Abstract][Full Text] [Related]